Sex-specific associations with cerebrospinal fluid biomarkers in dementia with Lewy bodies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Sex-specific associations with cerebrospinal fluid biomarkers in dementia with Lewy bodies ; volume:12 ; number:1 ; day:17 ; month:4 ; year:2020 ; pages:1-8 ; date:12.2020
Alzheimer's research & therapy ; 12, Heft 1 (17.4.2020), 1-8, 12.2020
- Creator
-
van de Beek, M.
Babapour Mofrad, R.
van Steenoven, I.
Vanderstichele, H.
Scheltens, P.
Teunissen, C. E.
Lemstra, A. W.
van der Flier, W. M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-020-00610-9
- URN
-
urn:nbn:de:101:1-2020062922055761277216
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- van de Beek, M.
- Babapour Mofrad, R.
- van Steenoven, I.
- Vanderstichele, H.
- Scheltens, P.
- Teunissen, C. E.
- Lemstra, A. W.
- van der Flier, W. M.
- SpringerLink (Online service)
Other Objects (12)
VGF peptides in cerebrospinal fluid of patients with dementia with lewy bodies
Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
Dementia with Lewy Bodies
Young-Onset Dementia with Lewy Bodies
Microbleeds in dementia with Lewy bodies
Tau Protein, Aβ42 and S-100B Protein in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies
Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach
Dementia with Lewy bodies – a clinicopathological update
Pharmacological Management of Dementia with Lewy Bodies
Gut microbiota in dementia with Lewy bodies
Visual dysfunction in dementia with Lewy bodies
Reply: Matters Arising ‘Lewy body disease or diseases with Lewy bodies?’
VGF peptides in cerebrospinal fluid of patients with dementia with lewy bodies
Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
Dementia with Lewy Bodies
Young-Onset Dementia with Lewy Bodies
Microbleeds in dementia with Lewy bodies
Tau Protein, Aβ42 and S-100B Protein in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies
Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach
Dementia with Lewy bodies – a clinicopathological update
Pharmacological Management of Dementia with Lewy Bodies
Gut microbiota in dementia with Lewy bodies
Visual dysfunction in dementia with Lewy bodies
Reply: Matters Arising ‘Lewy body disease or diseases with Lewy bodies?’
VGF peptides in cerebrospinal fluid of patients with dementia with lewy bodies
Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
Dementia with Lewy Bodies
Young-Onset Dementia with Lewy Bodies
Microbleeds in dementia with Lewy bodies
Tau Protein, Aβ42 and S-100B Protein in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies
Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach
Dementia with Lewy bodies – a clinicopathological update
Pharmacological Management of Dementia with Lewy Bodies
Gut microbiota in dementia with Lewy bodies
Visual dysfunction in dementia with Lewy bodies